672 results match your criteria: "Lou Ruvo Center for Brain Health[Affiliation]"

Background: Cognitive impairment is common sequelae of multiple sclerosis (MS); however, relatively little is known about cognitive impairment in late-onset multiple sclerosis (LOMS).

Objective: To investigate differences in disease characteristics and cognition in LOMS and adult-onset multiple sclerosis (AOMS) patients.

Methods: Archival medical records and neuropsychological evaluations from an MS specialty center were reviewed.

View Article and Find Full Text PDF

Sex differences in Alzheimer's disease: do differences in tau explain the verbal memory gap?

Neurobiol Aging

November 2021

Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA; Department of Radiology, University of California, San Diego, La Jolla, CA, USA.

To determine if sex differences in verbal memory in AD are related to differences in extent or distribution of pathological tau, we studied 275 participants who were amyloid PET positive and carried clinical classifications of normal cognition, mild cognitive impairment (MCI) or dementia, and had tau (AV1451) PET. We compared tau distribution between men and women, and as a function of genetic risk. In MCI we further explored the relationship between quantity and distribution of tau in relation to verbal memory scores.

View Article and Find Full Text PDF

Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project.

Alzheimers Res Ther

August 2021

Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Departments of Neurology, Neurosurgery, and Anatomy & Neurobiology, Boston University School of Medicine, Boston, MA, USA.

Article Synopsis
  • Chronic traumatic encephalopathy (CTE) is a serious brain disease caused by repeated head impacts and can only be diagnosed after death; the DIAGNOSE CTE Research Project aims to develop diagnostic methods for this condition.
  • Funded by the National Institute of Neurological Disorders and Stroke, the project includes 240 male participants, focusing on former football players and asymptomatic individuals, to study various risk factors and biomarkers related to CTE.
  • The research involves extensive evaluations such as neurological exams, brain imaging, and biological sample collection, with a focus on refining clinical criteria and sharing data with the broader research community.
View Article and Find Full Text PDF

Background: Postural instability (PI) in Parkinson's disease (PD) is associated with several negative downstream consequences.

Objective: The purpose was to explore the validity of a theoretical model of these downstream consequences arranged in a vicious cycle wherein PI leads to decreased balance confidence, which in turn leads to increased fear of falling (FOF) avoidance behavior, which in turn leads to decreased physical conditioning, which then feeds back and negatively affects PI.

Methods: A path analysis of cross-sectional data from 55 participants with PD was conducted.

View Article and Find Full Text PDF

Anxiety in Parkinson's Disease: A Systematic Review of Neuroimaging Studies.

J Neuropsychiatry Clin Neurosci

November 2021

Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore (Perepezko, Bakker); Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine (Naaz, Wagandt, Nanavati, Bakker, Pontone); University of Queensland Centre for Clinical Research, Faculty of Medicine, Brisbane, Australia (Dissanayaka); School of Psychology, University of Queensland (Dissanayaka); Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Australia (Dissanayaka); Department of Neurology, Johns Hopkins University School of Medicine (Mari, Bakker, Pontone); and Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas (Mari).

Objective: The mechanisms and neuronal networks associated with anxiety in Parkinson's disease (PD) are incompletely understood. One of the best tools for investigating both component function and neuronal networks associated with psychiatric symptoms is functional MRI (fMRI). Unlike structural scans, functional scans, whether task-based or resting-state, are more likely to be clinically relevant and sensitive to changes related to treatment.

View Article and Find Full Text PDF

Inflammatory changes are among the key markers of Alzheimer's disease (AD) related pathological changes. Pro-inflammatory analytes have been related to cognitive decline while others have been related to attenuating neuronal death. Among them, changes in cerebrospinal fluid (CSF) levels of soluble triggering receptor expressed on myeloid cells 2 (sTREM2) and soluble tumor necrosis factor receptor 2 (sTNFR2) have been described as impacting favorable clinical outcomes in AD.

View Article and Find Full Text PDF

Telemedicine and Deep brain stimulation - Current practices and recommendations.

Parkinsonism Relat Disord

August 2021

Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada. Division of Neurology, University of Toronto, Toronto, Ontario, Canada; Krembil Brain Institute, Toronto, Ontario, Canada; Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, ON, Canada.

The use of telemedicine in the management of chronic neurological conditions including movement disorders has expanded over time. In addition to enabling remote access to specialized care, telemedicine has also been shown to reduce caregiver burden and to improve patient satisfaction. With the COVID-19 pandemic, implementation of telehealth for patients with movement disorders, particularly those with more severe mobility issues, has increased rapidly.

View Article and Find Full Text PDF

In 2019, the Lewy Body Dementia Association formed an Industry Advisory Council to bring together a collaborative group of stakeholders with the goal of accelerating clinical research into Lewy body dementia treatments. At the second annual meeting of the Industry Advisory Council, held virtually on June 18, 2020, the key members presented ongoing and planned efforts toward the council's goals. The meeting also featured a discussion about the effects of the COVID-19 pandemic on Lewy body dementia clinical research, lessons learned from that experience, and how those lessons can be applied to the design and conduct of future clinical trials.

View Article and Find Full Text PDF

Cerebellar transcranial direct current stimulation (c-tDCS) enhances motor skill acquisition and motor learning in young and old adults. Since the cerebellum is involved in the pathophysiology of Parkinson's disease (PD), c-tDCS may represent an intervention with potential to improve motor learning in PD. The primary purpose was to determine the influence of long-term application of c-tDCS on motor learning in PD.

View Article and Find Full Text PDF

Traumatic brain injury (TBI) is a common source of functional impairment among athletes, military personnel, and the general population. Professional fighters in both boxing and mixed martial arts (MMA) are at particular risk for repetitive TBI and may provide valuable insight into both the pathophysiology of TBI and its consequences. Currently, effects of fighter weight class on brain volumetrics (regional and total) and functional outcomes are unknown.

View Article and Find Full Text PDF

Is computerized screening for processing speed impairment sufficient for identifying MS-related cognitive impairment in a clinical setting?

Mult Scler Relat Disord

September 2021

Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, OH, United States; Lou Ruvo Center for Brain Health, Neurological Institute, Cleveland Clinic, Cleveland, OH.

Background: Annual screening for processing speed impairment (PSI) is recommended for patients with multiple sclerosis (pwMS). However, cognitive deficits in pwMS are heterogeneous, and whether PSI screening identifies patients with impairment in other cognitive domains is unclear. The objective of this study was to examine sensitivity and specificity of the self-administered, computerized Processing Speed Test (PST) in identifying cognitive impairment defined by a comprehensive neuropsychological battery (NPT).

View Article and Find Full Text PDF
Article Synopsis
  • The HEADWAY-DLB study investigated the effectiveness of intepirdine, a serotonin receptor antagonist, in treating dementia with Lewy bodies (DLB) through a phase 2b clinical trial.
  • The trial involved 269 participants who were randomly assigned to receive either a placebo, 70 mg/day intepirdine, or 35 mg/day intepirdine over a 24-week period, measuring changes in motor symptoms using the UPDRS-III scale.
  • Results showed no significant improvement for either intepirdine dose compared to placebo, indicating that while the drug was generally well-tolerated, it did not provide benefits in treating DLB symptoms.
View Article and Find Full Text PDF

Objective: Story memory tasks are among the most commonly used memory tests; however, research suggests they may be less sensitive to memory decline and have a weaker association with hippocampal volumes than list learning tasks. To examine its utility, we compared story memory to other memory tests on impairment rates and association with hippocampal volumes.

Method: Archival records from 1617 older adults (M = 74.

View Article and Find Full Text PDF

Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer's Disease.

J Alzheimers Dis

September 2021

Memory and Alzheimer's Treatment Center & Alzheimer's Disease Research Center, Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Background: Age may affect treatment outcome in trials of mild probable Alzheimer's disease (AD).

Objective: We examined age as a moderator of outcome in an exploratory study of deep brain stimulation targeting the fornix (DBS-f) region in participants with AD.

Methods: Forty-two participants were implanted with DBS electrodes and randomized to double-blind DBS-f stimulation ("on") or sham DBS-f ("off") for 12 months.

View Article and Find Full Text PDF

Objectives: Mild cognitive impairment (MCI) types may have distinct neuropathological substrates with hippocampal atrophy particularly common in amnestic MCI (aMCI). However, depending on the MCI classification criteria applied to the sample (e.g.

View Article and Find Full Text PDF
Article Synopsis
  • The amyloid cascade hypothesis suggests that clearing amyloid beta (Aβ) could potentially cure Alzheimer's disease (AD), but previous treatments have shown limited success, prompting researchers to explore new therapeutic strategies like immunotherapy.
  • Currently, several monoclonal antibody (mAb) therapies aimed at targeting and removing Aβ plaques are under development, including aducanumab, lecanemab, solanezumab, crenezumab, donanemab, and gantenerumab, which could be effective at various stages of AD.
  • The FDA's upcoming decision on aducanumab is expected to significantly influence the future of mAb drug development for AD, and there's a call for improved trial designs to enhance treatment outcomes and
View Article and Find Full Text PDF

Background: Dementia-like cognitive impairment is an increasingly reported complication of SARS-CoV-2 infection. However, the underlying mechanisms responsible for this complication remain unclear. A better understanding of causative processes by which COVID-19 may lead to cognitive impairment is essential for developing preventive and therapeutic interventions.

View Article and Find Full Text PDF
Article Synopsis
  • A phase 3 trial called MINDSET tested the effectiveness of the drug intepirdine in combination with donepezil for patients with mild-to-moderate Alzheimer's disease.
  • The study involved 1,315 patients and aimed to measure changes in cognitive function and daily living activities after 24 weeks of treatment.
  • Results showed no significant improvement in cognitive or daily living abilities with intepirdine compared to placebo, while the safety profile was similar for both groups.
View Article and Find Full Text PDF

Traditionally, functional networks in resting-state data were investigated with linear Fourier and wavelet-related methods to characterize their frequency content by relying on pre-specified frequency bands. In this study, Empirical Mode Decomposition (EMD), an adaptive time-frequency method, is used to investigate the naturally occurring frequency bands of resting-state data obtained by Group Independent Component Analysis. Specifically, energy-period profiles of Intrinsic Mode Functions (IMFs) obtained by EMD are created and compared for different resting-state networks.

View Article and Find Full Text PDF

The present review asks whether magnetic resonance imaging (MRI) studies are able to define neural correlates of episodic memory within the hippocampus in Parkinson's disease (PD). Systematic searches were performed in PubMed, Web of Science, Medline, CINAHL, and EMBASE using search terms related to structural and functional MRI (fMRI), the hippocampus, episodic memory, and PD. Risk of bias was assessed for each study using the Newtown-Ottawa Scale.

View Article and Find Full Text PDF

Background: Informant-based measures are effective screening tools for cognitive impairment. The Alzheimer's Questionnaire (AQ) is a subjective, informant-based measure that detects amnestic mild cognitive impairment (aMCI) and Alzheimer's disease (AD) with high sensitivity and specificity and has been shown to predict amyloid burden.

Objective: To determine whether informant-based report of cognitive decline correlates with hippocampal volume changes in MCI and AD.

View Article and Find Full Text PDF

Down syndrome is the phenotypic consequence of trisomy 21, with clinical presentation including both neurodevelopmental and neurodegenerative components. Although the intellectual disability typically displayed by individuals with Down syndrome is generally global, it also involves disproportionate deficits in hippocampally-mediated cognitive processes. Hippocampal dysfunction may also relate to Alzheimer's disease-type pathology, which can appear in as early as the first decade of life and becomes universal by age 40.

View Article and Find Full Text PDF

Zonisamide is an anti-epileptic medication with multiple mechanisms of action and a favorable safety profile. Zonisamide may interact with Lewy body dementia pathophysiology through a mechanism unrelated to its original indication. Zonisamide has shown efficacy as adjunct therapy for the management of motor symptoms in patients with Parkinson's disease (PD).

View Article and Find Full Text PDF